
Article 1 
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Article 2 
This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 27 June 2018.
For the Commission
The President
Jean-Claude JUNCKER
ANNEX

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

((1)) in the sixth column, expiration of approval, of row 15, Diquat, the date is replaced by ‘30 June 2019’;
((2)) in the sixth column, expiration of approval, of row 23, Pymetrozine, the date is replaced by ‘30 June 2019’;
((3)) in the sixth column, expiration of approval, of row 35, Famoxadone, the date is replaced by ‘30 June 2019’;
((4)) in the sixth column, expiration of approval, of row 37, Metalaxyl-M, the date is replaced by ‘30 June 2019’;
((5)) in the sixth column, expiration of approval, of row 39, Flumioxazine, the date is replaced by ‘30 June 2019’;
((6)) in the sixth column, expiration of approval, of row 42, Oxasulfuron, the date is replaced by ‘31 July 2019’;
((7)) in the sixth column, expiration of approval, of row 44, Foramsulfuron, the date is replaced by ‘31 July 2019’;
((8)) in the sixth column, expiration of approval, of row 46, Cyazofamid, the date is replaced by ‘31 July 2019’;
((9)) in the sixth column, expiration of approval, of row 62, Fenamidone, the date is replaced by ‘31 July 2019’;
((10)) in the sixth column, expiration of approval, of row 63, Isoxaflutole, the date is replaced by ‘31 July 2019’;
((11)) in the sixth column, expiration of approval, of row 78, Chlorpropham, the date is replaced by ‘31 July 2019’;
((12)) in the sixth column, expiration of approval, of row 83, Alpha-cypermethrin, the date is replaced by ‘31 July 2019’;
((13)) in the sixth column, expiration of approval, of row 84, Benalaxyl, the date is replaced by ‘31 July 2019’;
((14)) in the sixth column, expiration of approval, of row 85, Bromoxynil, the date is replaced by ‘31 July 2019’;
((15)) in the sixth column, expiration of approval, of row 86, Desmedipham, the date is replaced by ‘31 July 2019’;
((16)) in the sixth column, expiration of approval, of row 88, Phenmedipham, the date is replaced by ‘31 July 2019’;
((17)) in the sixth column, expiration of approval, of row 96, Methoxyfenozide, the date is replaced by ‘31 July 2019’;
((18)) in the sixth column, expiration of approval, of row 97, S-metolachlor, the date is replaced by ‘31 July 2019’;
((19)) in the sixth column, expiration of approval, of row 98, Gliocladium catenulatum strain: J1446, the date is replaced by ‘31 July 2019’;
((20)) in the sixth column, expiration of approval, of row 99, Etoxazole, the date is replaced by ‘31 July 2019’;
((21)) in the sixth column, expiration of approval, of row 109, Bifenazate, the date is replaced by ‘31 July 2019’;
((22)) in the sixth column, expiration of approval, of row 110, Milbemectin, the date is replaced by ‘31 July 2019’;
((23)) in the sixth column, expiration of approval, of row 141, Fenamiphos, the date is replaced by ‘31 July 2019’;
((24)) in the sixth column, expiration of approval, of row 142, Ethephon, the date is replaced by ‘31 July 2019’;
((25)) in the sixth column, expiration of approval, of row 145, Captan, the date is replaced by ‘31 July 2019’;
((26)) in the sixth column, expiration of approval, of row 146, Folpet, the date is replaced by ‘31 July 2019’;
((27)) in the sixth column, expiration of approval, of row 147, Formetanate, the date is replaced by ‘31 July 2019’;
((28)) in the sixth column, expiration of approval, of row 148, Methiocarb, the date is replaced by ‘31 July 2019’;
((29)) in the sixth column, expiration of approval, of row 149, Dimethoate, the date is replaced by ‘31 July 2019’;
((30)) in the sixth column, expiration of approval, of row 150, Dimethomorph, the date is replaced by ‘31 July 2019’;
((31)) in the sixth column, expiration of approval, of row 152, Metribuzin, the date is replaced by ‘31 July 2019’;
((32)) in the sixth column, expiration of approval, of row 153, Phosmet, the date is replaced by ‘31 July 2019’;
((33)) in the sixth column, expiration of approval, of row 154, Propamocarb, the date is replaced by ‘31 July 2019’;
((34)) in the sixth column, expiration of approval, of row 155, ethoprophos, the date is replaced by ‘31 July 2019’;
((35)) in the sixth column, expiration of approval, of row 156, Pirimiphos-methyl, the date is replaced by ‘31 July 2019’;
((36)) in the sixth column, expiration of approval, of row 158, Beflubutamid, the date is replaced by ‘31 July 2019’;
((37)) in the sixth column, expiration of approval, of row 163, Benthiavalicarb, the date is replaced by ‘31 July 2019’;
((38)) in the sixth column, expiration of approval, of row 164, Boscalid, the date is replaced by ‘31 July 2019’;
((39)) in the sixth column, expiration of approval, of row 165, Carvone, the date is replaced by ‘31 July 2019’;
((40)) in the sixth column, expiration of approval, of row 166, Fluoxastrobin, the date is replaced by ‘31 July 2019’;
((41)) in the sixth column, expiration of approval, of row 167, Paecilomyces lilacinus strain 251, the date is replaced by ‘31 July 2019’;
((42)) in the sixth column, expiration of approval, of row 168, Prothioconazole, the date is replaced by ‘31 July 2019’.
